These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19910733)

  • 1. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can non-randomized trials be considered to be equivalent to randomized trials in forensic mental health?
    Leese M
    Crim Behav Ment Health; 2005; 15(2):121-2. PubMed ID: 16470506
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommended guidelines for studies of human subjects with spinal cord injury.
    Anderson DK; Beattie M; Blesch A; Bresnahan J; Bunge M; Dietrich D; Dietz V; Dobkin B; Fawcett J; Fehlings M; Fischer I; Grossman R; Guest J; Hagg T; Hall ED; Houle J; Kleitman N; McDonald J; Murray M; Privat A; Reier P; Steeves J; Steward O; Tetzlaff W; Tuszynski MH; Waxman SG; Whittemore S; Wolpaw J; Young W; Zheng B
    Spinal Cord; 2005 Aug; 43(8):453-8. PubMed ID: 15824756
    [No Abstract]   [Full Text] [Related]  

  • 9. New author guidelines - clinical trials and conflict of interest.
    Foster A
    Vet Dermatol; 2008 Apr; 19(2):51. PubMed ID: 18336420
    [No Abstract]   [Full Text] [Related]  

  • 10. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events in randomized trials: neglected, restricted, distorted, and silenced.
    Ioannidis JP
    Arch Intern Med; 2009 Oct; 169(19):1737-9. PubMed ID: 19858427
    [No Abstract]   [Full Text] [Related]  

  • 12. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 13. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 15. On clinical trials in psychiatry.
    Greenhouse JB
    Biol Psychiatry; 2000 Sep; 48(6):433-5. PubMed ID: 11018215
    [No Abstract]   [Full Text] [Related]  

  • 16. ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement?
    Ozdemir V; Joly Y; Knoppers BM
    Am J Bioeth; 2011 Mar; 11(3):11-3. PubMed ID: 21400375
    [No Abstract]   [Full Text] [Related]  

  • 17. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 18. Independent design and conduct of clinical trials.
    Yusuf S; Bosch J
    Clin Trials; 2006; 3(6):503-7. PubMed ID: 17170033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 20. The case for practical clinical trials in psychiatry.
    March JS; Silva SG; Compton S; Shapiro M; Califf R; Krishnan R
    Am J Psychiatry; 2005 May; 162(5):836-46. PubMed ID: 15863782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.